is retatrutide a glp 1 drug vs Tirzepatide vs Semaglutide New Weight Loss Drug -

55 pM for GLP-1 in one cellular assay (99)

Substance use disorders An emerging area of interest for GLP-1RAs is their potential role in the treatment of substance use disorders, including alcohol and nicotine dependence.[51] GLP-1 is endogenously produced in the nucleus tractus solitarius of the brainstem and acts as a neuropeptide modulating reward and addiction pathways.[52, 53] GLP-1 receptors are expressed in key regions involved in reinforcement, including the ventral tegmental area and nucleus accumbens, where they modulate glutamatergic signaling, potentially influencing feeding and substance-related behaviors.[53, 54] Though ongoing trials are actively investigating the role of GLP-1RAs in substance use disorders, the current evidence base is constrained by a small number of studies, limited randomized controlled trials, heterogeneity in agents evaluated, and variability in outcome measures.[55] One cohort study of U.S

[DOI] [PubMed] 78.Wadden TA, Foreyt JP, Foster GD, et al

These risks need to be discussed openly so patients and providers can make informed decisions

In terms of logistics, its fairly simple